Member Info for Gallmat

It is rare to see an rns without a negative, yet some can still find them :)

Be a good idea not to follow the company and invest elsewhere.

Why all the scare mongering on cash.

They are going to produce 30k a year, they are covering overheads and making good margin on expanded capacity.

Low cost producer, great margin

Nothing to worry about, apart from worrying about worrying

I had to sell at a loss on this a while ago.

But then i found a better companies and started to recoup. Wishing you the best.

The CEO is milking the IC coverage to pump and raise. I am surprised ST still writes up on them because another company did this once qnd he took a dim view

The new deal was a red flag for me.
If it is really good news, they might need capital etc.

Always same pattern.
News
Simon thompson. Spike
Placing.

Only way to is to trade this baby as above.

If ST throws in towel, strategy is over.
If not wait for dip to 4p and buy the dip

If you like healthcare avct.

They are developing targeted chemopherapy.
Delivering an existing drug without side effects.
Avct. Good write up on aim chaos.

Going into effectiveness trials soon. But key thing is in safety trial they showed.
. No bad side effects
. The existing drug was found in the cancer cells.

So lower risk than normal. Because we know the drug they deliver works normally, this issue is side effects :).

Could be very big as it is a delivery platform that could be used to make many types of existing chemo be delivered without the worst side effects.

No tip here, no expert but read aim chaos.

I think lit.l is a nice IC tip.

The company only release info when cases complete. If you check the board, we have a big case representing 30k people in class action.

Judge has been quoted as being fruatrated that thr defendant did not settle yet.

Similar case on same topic by same lawyers had an award of 200m aud.

8 week trial i think

I held about 10. Ranging from 3 days to 4 yrs.

Some tips are compounders. Just good businesses thaat grow ( telford homes etc). Other strategies can be to monitor old tips, wait for the drift until they become bargains again and buy during news blackouts.

One thing is that he is loyal to his stocks. If i see something not doing so well, i cut and run quick ( cfo quits etc). He is not a realtime service and by the time he releases commentary stocks can drop and often he is them forced to say hold ( as the nature of his picks are to havd margin of safety)

Not the best of news. But this will slowdown the development pipeline.

If tgr can build at an appropriate scale with lower costs it may not be so gloomy.

Followed him for years. Many outperform.

Also what is issue with buying and selling the spike.

Not sure. Made over 100k on his tips.
He gets some wrong, but if you buy a diversified set of picks. Sell if bad stock specific news comes out i think you do ok.

And this is what he tells people to do

Is your take from thw article. That the judge sees a valid pfas claim and they are arguing about the amount.

The studiea are performed by the defendant, and they are claiming for lost property values.

Surely any form of polution even minor will have an impact on their values.

Glad to converse with someone on a board who posts rational facts :).

I was aware of the second item, on my watch list.

It does feel like there is value in tracking some of the larger cases even if there is a cost. There is a nicee grey level pf information in the market before lcm put out the black and white rns

Always good to buy a ST tip.
Has the power to drive it up and rerate.
Puts a bit of a floor on the downward drift

This is a recovery play.
Earnigns are at level expected. Nhs striking, still winning contracts.

Have to expect downs and ups.

Are you a subscriber to the website? Or just gping off the title?

Confirm we funded
https://www.who.com.au/katy-perry-sued-by-australian-designer-of-same-name

Confirmation of win
https://www.news.com.au/entertainment/music/katy-perry-loses-federal-court-battle-with-aussie-fashion-designer/news-story/27ded4be93eb020595d73712c325efad

Yup. Sell out
Buy back

They do not make money.
Ceo promisses progress, none comes and they dilute with continued equity raises.

Sadly they have a bad reputation for being vague, not delivering and diluting.

A good stock to play on news releases but not one to hold.

Thw volume explains all. Intense on article, now everyone loosing interest

Agree. Stage 1b is 6 to 18 cycles at 3 weeks a cycle.
Do the math. Given we hope to be able to do extra cycles ( more than 6 in current solution). This could take 12 to 18 x 3 weeks.

Add in it has not started yet.

Yes, great tech. But there will be a long wait and this is aim. An offer could come, but no reason for one just yet